NPI: 1780608216 · PORTLAND, OR 97210 · Durable Medical Equipment & Medical Supplies · NPI assigned 07/27/2006
Authorized official JENSEN, SARAH controls 20+ related entities in our dataset. Read more
| Authorized Official | JENSEN, SARAH (VP FINANCE) |
| NPI Enumeration Date | 07/27/2006 |
Other providers sharing the same authorized official: JENSEN, SARAH
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 34,094 | $1.60M |
| 2019 | 35,785 | $2.08M |
| 2020 | 30,672 | $2.03M |
| 2021 | 40,020 | $2.77M |
| 2022 | 48,546 | $3.18M |
| 2023 | 39,481 | $3.41M |
| 2024 | 34,797 | $3.26M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 21,009 | 19,104 | $6.54M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 19,149 | 17,799 | $4.55M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 18,429 | 16,946 | $3.06M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 7,699 | 7,144 | $926K |
| 19318 | 152 | 146 | $701K | |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 11,602 | 10,727 | $621K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 9,315 | 7,898 | $352K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 3,131 | 2,992 | $260K |
| 92134 | 8,879 | 8,011 | $185K | |
| 19303 | 39 | 39 | $178K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 2,890 | 2,407 | $140K |
| 71046 | Radiologic examination, chest; 2 views | 2,252 | 2,076 | $96K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1,720 | 1,584 | $71K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 14,443 | 10,936 | $67K |
| 71271 | 1,261 | 1,205 | $63K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 645 | 597 | $53K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1,463 | 1,321 | $52K |
| 70450 | Computed tomography, head or brain; without contrast material | 394 | 368 | $46K |
| 95811 | 77 | 74 | $42K | |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 825 | 510 | $29K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 466 | 433 | $25K |
| 71045 | Radiologic examination, chest; single view | 500 | 463 | $22K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 19,095 | 17,358 | $21K |
| 67028 | Intravitreal injection of a pharmacologic agent | 1,164 | 934 | $21K |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | 40 | 36 | $21K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 104 | 99 | $21K |
| G0297 | Low dose ct scan (ldct) for lung cancer screening | 663 | 637 | $16K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 142 | 133 | $15K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 28 | 25 | $15K |
| 92285 | 469 | 420 | $15K | |
| E0601 | Continuous positive airway pressure (cpap) device | 210 | 192 | $14K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 105 | 97 | $11K |
| 10061 | 59 | 50 | $10K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 73 | 67 | $9K |
| 80053 | Comprehensive metabolic panel | 21,817 | 19,992 | $6K |
| 92083 | 119 | 105 | $6K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 40,219 | 36,465 | $5K |
| 97542 | 229 | 186 | $5K | |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | 40 | 39 | $4K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 322 | 301 | $3K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 495 | 455 | $3K |
| 94060 | 59 | 53 | $3K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 95 | 76 | $3K |
| 73630 | 124 | 105 | $3K | |
| 97165 | 26 | 26 | $2K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 9,463 | 8,693 | $2K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 47 | 43 | $2K |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 15 | 15 | $1K |
| 97161 | 24 | 24 | $1K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 262 | 114 | $1K |
| J3490 | Unclassified drugs | 2,441 | 1,860 | $1K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 736 | 635 | $931.03 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 207 | 201 | $869.19 |
| 84484 | 7,347 | 6,568 | $856.98 | |
| 94799 | 236 | 225 | $805.00 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 157 | 145 | $801.22 |
| 73610 | 14 | 13 | $784.89 | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 15 | 15 | $617.85 |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 38 | 35 | $548.23 |
| 87070 | 98 | 95 | $505.14 | |
| 99441 | 98 | 84 | $468.44 | |
| 92133 | 24 | 24 | $425.52 | |
| 97535 | Self-care/home management training, each 15 minutes | 88 | 71 | $375.60 |
| A4604 | Tubing with integrated heating element for use with positive airway pressure device | 13 | 13 | $351.08 |
| 84703 | 1,867 | 1,749 | $335.94 | |
| 81001 | 3,026 | 2,621 | $307.21 | |
| 36415 | Collection of venous blood by venipuncture | 6,860 | 5,914 | $257.73 |
| J2704 | Injection, propofol, 10 mg | 2,289 | 1,312 | $231.33 |
| 87631 | 28 | 24 | $218.56 | |
| 97162 | 13 | 12 | $206.86 | |
| A6212 | Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing | 111 | 105 | $192.40 |
| 83690 | 3,192 | 2,974 | $182.02 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 414 | 218 | $162.02 |
| 94726 | 47 | 41 | $160.28 | |
| 83735 | 762 | 539 | $155.61 | |
| 94729 | 47 | 41 | $119.08 | |
| 93308 | 14 | 12 | $117.87 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 1,692 | 1,398 | $87.43 |
| 80197 | 223 | 108 | $77.79 | |
| 97116 | 149 | 75 | $71.11 | |
| 87799 | 19 | 14 | $64.26 | |
| 87205 | 24 | 24 | $60.44 | |
| 81003 | 947 | 901 | $48.42 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 1,351 | 1,158 | $41.86 |
| 93321 | 14 | 12 | $34.12 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 569 | 446 | $28.00 |
| 83880 | 190 | 168 | $27.00 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 722 | 638 | $18.64 |
| A9270 | Non-covered item or service | 59 | 26 | $15.54 |
| J9035 | Injection, bevacizumab, 10 mg | 28 | 24 | $14.71 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 869 | 733 | $11.37 |
| 82570 | 15 | 12 | $7.77 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 1,408 | 1,296 | $7.20 |
| 80069 | 43 | 27 | $6.94 | |
| 81025 | 111 | 108 | $6.89 | |
| 84156 | 15 | 12 | $5.50 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 100 | 62 | $5.20 |
| J0690 | Injection, cefazolin sodium, 500 mg | 548 | 383 | $4.80 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 98 | 89 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 856 | 756 | $0.00 |
| 87641 | 77 | 73 | $0.00 | |
| J0689 | Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg | 31 | 31 | $0.00 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 29 | 26 | $0.00 |
| C1776 | Joint device (implantable) | 72 | 64 | $0.00 |
| 80299 | 18 | 15 | $0.00 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 30 | 28 | $0.00 |
| 36592 | 30 | 29 | $0.00 | |
| L8699 | Prosthetic implant, not otherwise specified | 52 | 52 | $0.00 |
| 82077 | 507 | 452 | $0.00 | |
| V2632 | Posterior chamber intraocular lens | 95 | 85 | $0.00 |
| 36416 | 54 | 51 | $0.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 43 | 43 | $0.00 |
| J7999 | Compounded drug, not otherwise classified | 137 | 113 | $0.00 |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 29 | 25 | $0.00 |
| 92567 | 75 | 69 | $0.00 | |
| 85027 | 36 | 27 | $0.00 |